Prices delayed by at least 15 minutes | Print
Cerus Corp (CERS)
Common SharesCompany profile
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
Address
1220 Concord Avenue
Suite 600
Concord
CA
USA
94520
Telephone
+1 925 2886137
Forecast key dates
Name | Key Date |
---|---|
Cerus Corp Fourth Quarter Earnings Conference Call for 2024 | 2025-03-05T16:30:00 |
Cerus Corp Fourth Quarter Earnings Results for 2024 | 2025-03-05T00:00:00 |
Cerus Corp Annual Report for 2024 | 2025-03-05T00:00:00 |
Cerus Corp Third Quarter Earnings Conference Call for 2024 | 2024-11-01T16:30:00 |
Cerus Corp Third Quarter Earnings Results for 2024 | 2024-11-01T00:00:00 |
Cerus Corp Second Quarter Earnings Conference Call for 2024 | 2024-08-02T16:30:00 |
Cerus Corp Second Quarter Earnings Results for 2024 | 2024-08-02T00:00:00 |
Cerus Corp Annual General Meeting for 2024 | 2024-06-07T09:00:00 |
Cerus Corp First Quarter Earnings Conference Call for 2024 | 2024-05-02T16:30:00 |
Cerus Corp First Quarter Earnings Result for 2024 | 2024-05-02T00:00:00 |
Previous key dates
Name | Key Date |
---|---|
Cerus Investor Call for ReCePI Results | 2024-03-19T09:00:00 |
TD Cowen 44th Annual Health Care Conference | 2024-03-06T11:10:00 |
Cerus Corp Fourth Quarter Earnings Conference Call for 2023 | 2024-03-05T16:30:00 |
Cerus Corp Fourth Quarter Earnings Result for 2023 | 2024-03-05T00:00:00 |
Cerus Corp Annual Report for 2023 | 2024-03-05T00:00:00 |
Cerus Corp Third Quarter Earnings Conference Call for 2023 | 2023-11-02T16:30:00 |
Cerus Corp Third Quarter Earnings Result for 2023 | 2023-11-02T00:00:00 |
Cerus Corp Second Quarter Earnings Conference Call for 2023 | 2023-08-02T16:30:00 |
Cerus Corp Second Quarter Earnings Result for 2023 | 2023-08-02T00:00:00 |
Cerus Corp Annual General Meeting for 2023 | 2023-06-07T09:00:00 |
Cerus Corp First Quarter Earnings Conference Call for 2023 | 2023-05-04T16:30:00 |
Cerus Corp First Quarter Earnings Result for 2023 | 2023-05-04T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.